Administration of a selective IL-6-trans-signalling inhibitor
The invention relates to administration of a selective IL-6-trans-signalling inhibitor. According to the invention, a selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6- mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be adminis...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
29.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention relates to administration of a selective IL-6-trans-signalling inhibitor. According to the invention, a selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6- mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses. Moreover, the inhibitor lessens deleterious effects associated with other IL-6 inhibitors such as lowering neutrophil counts, platelet counts and levels of C-reactive protein.
选择性IL-6-跨信号转导抑制剂可以被用于治疗各种IL-6介导的病症,包括炎性疾病和癌症。抑制剂可以安全地以各种剂量施用于人类。此外,抑制剂减轻与其他IL-6抑制剂相关的有害作用诸如降低中性粒细胞计数、血小板计数和C反应蛋白的水平。 |
---|---|
Bibliography: | Application Number: CN201580075096 |